APOLIPOPROTEIN B - ANVISA Registration 80146502192
Access comprehensive regulatory information for APOLIPOPROTEIN B in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502192 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, DIASYS DIAGNOSTIC SYSTEMS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80146502192
25351856279201867
56998701000116
Company Information
Dates and Status
Mar 18, 2019
VIGENTE
09/18/2025 19:00:01
APOLIPOPROTEÍNA B
Apo B Turbiquest
LABTEST DIAGNOSTICA S/A
10009010459
Aug 05, 2024
APOLIPOPROTEÍNA B
FAMÍLIA DE REAGENTE, CALIBRADOR E CONTROLES Optilite® Apolipoprotein B
THE BINDING SITE GROUP LTD
81357320130
Jun 26, 2023
APOLIPOPROTEÍNA B
Apolipoprotein B
THERMO FISHER SCIENTIFIC OY
80254180418
May 19, 2022
APOLIPOPROTEÍNA B
APOBT (Tina-quant Apolipoprotein B ver.2)
ROCHE DIAGNOSTICS GMBH
10287411405
Jul 22, 2019
APOLIPOPROTEÍNA B
ox-LDL/MDA Adduct ELISA
IMMUNDIAGNOSTIK AG
80464810613
Oct 29, 2018

